Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Kenvue Inc (KVUE)

Kenvue Inc (KVUE)
20.50 x 1 22.58 x 2
Post-market by (Cboe BZX)
21.77 -0.56 (-2.51%) 04/07/25 [NYSE]
20.50 x 1 22.58 x 2
Post-market 21.69 -0.08 (-0.37%) 16:55 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
21.37
Day High
22.47
Open 22.01
Previous Close 22.33 22.33
Volume 26,811,494 26,811,494
Avg Vol 16,550,180 16,550,180
Stochastic %K 24.92% 24.92%
Weighted Alpha +10.25 +10.25
5-Day Change -2.21 (-9.22%) -2.21 (-9.22%)
52-Week Range 17.67 - 24.46 17.67 - 24.46
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,678,008
  • Shares Outstanding, K 1,911,241
  • Annual Sales, $ 15,455 M
  • Annual Income, $ 1,030 M
  • EBIT $ 1,841 M
  • EBITDA $ 2,463 M
  • 60-Month Beta 1.02
  • Price/Sales 2.92
  • Price/Cash Flow 16.05
  • Price/Book 4.68

Options Overview Details

View History
  • Implied Volatility 45.70% ( -4.78%)
  • Historical Volatility 25.35%
  • IV Percentile 98%
  • IV Rank 69.95%
  • IV High 57.53% on 02/05/25
  • IV Low 18.17% on 12/02/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 25,133
  • Volume Avg (30-Day) 17,790
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 270,863
  • Open Int (30-Day) 271,306

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.23
  • Number of Estimates 6
  • High Estimate 0.24
  • Low Estimate 0.21
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -17.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.37 +1.87%
on 04/07/25
Period Open: 23.42
24.35 -10.61%
on 03/10/25
-1.65 (-7.05%)
since 03/07/25
3-Month
19.75 +10.23%
on 02/06/25
Period Open: 21.05
24.36 -10.63%
on 03/04/25
+0.72 (+3.42%)
since 01/07/25
52-Week
17.67 +23.20%
on 07/11/24
Period Open: 20.25
24.46 -11.00%
on 11/26/24
+1.52 (+7.51%)
since 04/05/24

Most Recent Stories

More News
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign

/CNW/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid...

KVUE : 21.77 (-2.51%)
My Top High-Yield Dividend Stock to Buy in April (and It's Not Even Close)

Nearly a quarter through 2025, the S&P 500 (SNPINDEX: ^GSPC) is down year to date -- a noticeable step change after the index posted back-to-back 20% annual gains in 2023 and 2024.

TGT : 94.38 (-1.40%)
KMB : 134.54 (-2.44%)
HRL : 30.04 (-2.28%)
KO : 68.37 (-2.23%)
$SPX : 5,062.25 (-0.23%)
LANC : 175.42 (-2.44%)
CL : 89.19 (-2.69%)
SYY : 69.46 (-2.77%)
PG : 160.23 (-2.15%)
KVUE : 21.77 (-2.51%)
PEP : 143.19 (-2.33%)
WMT : 83.83 (+0.77%)
Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing tariffs...

ITCI : 131.87 (-0.04%)
JNJ : 150.62 (-1.71%)
KVUE : 21.77 (-2.51%)
AMGN : 289.69 (-1.60%)
Kenvue Stock In Focus As TOMS Capital Reportedly Pushes For Sale Or Breakup: Will It Shift Retail Mood?

Earlier this month, the company appointed three new directors, including Starboard Value CEO Jeffrey Smith, to its board as part of an agreement with the activist hedge fund after months of back-and-forth....

JNJ : 150.62 (-1.71%)
KVUE : 21.77 (-2.51%)
IPO : 33.28 (+0.12%)
FPX : 100.25 (+1.06%)
Honeywell Isn't Going to Let a Little Breakup Ruin Its Growth Plans

Investors are usually happy when a company can pull off one big goal and do it well. So Wall Street was almost certainly expecting Honeywell (NASDAQ: HON) to focus all of its attention in the immediate...

HON : 187.46 (-1.85%)
JNJ : 150.62 (-1.71%)
GEHC : 60.99 (+0.79%)
KVUE : 21.77 (-2.51%)
GEV : 286.07 (+5.37%)
GE : 167.70 (+0.53%)
Is Kenvue Stock Outperforming the S&P 500?

Kenvue has outperformed the S&P 500 Index over the past year and analysts remain moderately optimistic about its future outlook.

BDRFY : 24.6775 (-5.87%)
$SPX : 5,062.25 (-0.23%)
KVUE : 21.77 (-2.51%)
2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger

It's time for another Market Cap Game Show. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . To get started investing, check out our beginner's guide to investing...

GOOGL : 146.75 (+0.79%)
ROKU : 57.13 (+3.35%)
AAPL : 181.46 (-3.67%)
DDD : 2.0300 (+7.41%)
DDOG : 88.20 (+0.31%)
JNJ : 150.62 (-1.71%)
RXO : 14.21 (-1.86%)
QXO : 13.55 (-3.21%)
UA : 5.08 (-0.39%)
DUOL : 296.51 (+1.24%)
FICO : 1,713.20 (+2.34%)
SBUX : 80.00 (-2.56%)
3 Great Value Stocks That Could Crush the S&P 500 This Year

With the overall market looking expensive, it can be prudent for investors in search of new stocks to add to their portfolios to dig into companies that, for whatever reason, are trading at discounts....

KVUE : 21.77 (-2.51%)
MMM : 128.55 (+1.29%)
DVN : 28.61 (-2.39%)
3 Top High-Yield Dividend Stocks I Just Bought in My Retirement Account

I'm filling my retirement account with dividend stocks. While I like to see the passive income flow into my portfolio, that's not the main factor. The biggest reason is outperformance. Dividend stocks...

INVH : 31.44 (-3.38%)
$SPX : 5,062.25 (-0.23%)
ENB : 41.95 (-3.23%)
KVUE : 21.77 (-2.51%)
Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income

Kenvue (NYSE: KVUE) stock is down since completing its spin-off from Johnson & Johnson (NYSE: JNJ) in August 2023. But with more than a year of results now in the books, investors have had time to acclimate...

JNJ : 150.62 (-1.71%)
KVUE : 21.77 (-2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

See More

Key Turning Points

3rd Resistance Point 23.46
2nd Resistance Point 22.96
1st Resistance Point 22.37
Last Price 21.77
1st Support Level 21.27
2nd Support Level 20.77
3rd Support Level 20.18

See More

52-Week High 24.46
Fibonacci 61.8% 21.87
Last Price 21.77
Fibonacci 50% 21.06
Fibonacci 38.2% 20.26
52-Week Low 17.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades